219 related articles for article (PubMed ID: 9389593)
1. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography.
Imamura T; Ishii K; Sasaki M; Kitagaki H; Yamaji S; Hirono N; Shimomura T; Hashimoto M; Tanimukai S; Kazui H; Mori E
Neurosci Lett; 1997 Oct; 235(1-2):49-52. PubMed ID: 9389593
[TBL] [Abstract][Full Text] [Related]
2. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease.
Ishii K; Imamura T; Sasaki M; Yamaji S; Sakamoto S; Kitagaki H; Hashimoto M; Hirono N; Shimomura T; Mori E
Neurology; 1998 Jul; 51(1):125-30. PubMed ID: 9674790
[TBL] [Abstract][Full Text] [Related]
3. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
[TBL] [Abstract][Full Text] [Related]
4. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.
Nedelska Z; Senjem ML; Przybelski SA; Lesnick TG; Lowe VJ; Boeve BF; Arani A; Vemuri P; Graff-Radford J; Ferman TJ; Jones DT; Savica R; Knopman DS; Petersen RC; Jack CR; Kantarci K
Neuroimage Clin; 2018; 19():939-947. PubMed ID: 30003031
[TBL] [Abstract][Full Text] [Related]
5. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
[TBL] [Abstract][Full Text] [Related]
6. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
[TBL] [Abstract][Full Text] [Related]
7. Fully automatic differential diagnosis system for dementia with Lewy bodies and Alzheimer's disease using FDG-PET and 3D-SSP.
Kono AK; Ishii K; Sofue K; Miyamoto N; Sakamoto S; Mori E
Eur J Nucl Med Mol Imaging; 2007 Sep; 34(9):1490-7. PubMed ID: 17318545
[TBL] [Abstract][Full Text] [Related]
8. Occipital glucose metabolism in dementia with lewy bodies with and without Parkinsonism: a study using positron emission tomography.
Imamura T; Ishii K; Hirono N; Hashimoto M; Tanimukai S; Kazui H; Hanihara T; Sasaki M; Mori E
Dement Geriatr Cogn Disord; 2001; 12(3):194-7. PubMed ID: 11244212
[TBL] [Abstract][Full Text] [Related]
9. Distinguishing between dementia with Lewy bodies and Alzheimer's disease using metabolic patterns.
Ye BS; Lee S; Yoo H; Chung SJ; Lee YH; Choi Y; Lee PH; Sohn YH; Yun M
Neurobiol Aging; 2020 Mar; 87():11-17. PubMed ID: 31791660
[TBL] [Abstract][Full Text] [Related]
10. Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria.
Caminiti SP; Sala A; Iaccarino L; Beretta L; Pilotto A; Gianolli L; Iannaccone S; Magnani G; Padovani A; Ferini-Strambi L; Perani D
Alzheimers Res Ther; 2019 Feb; 11(1):20. PubMed ID: 30797240
[TBL] [Abstract][Full Text] [Related]
11. Regional glucose metabolic reduction in dementia with Lewy bodies is independent of amyloid deposition.
Ishii K; Hosokawa C; Hyodo T; Sakaguchi K; Usami K; Shimamoto K; Hosono M; Yamazoe Y; Murakami T
Ann Nucl Med; 2015 Jan; 29(1):78-83. PubMed ID: 25270712
[TBL] [Abstract][Full Text] [Related]
12. Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.
Iaccarino L; Marelli S; Iannaccone S; Magnani G; Ferini-Strambi L; Perani D
J Alzheimers Dis; 2016 Apr; 52(3):989-97. PubMed ID: 27060952
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
Imai M; Tanaka M; Sakata M; Wagatsuma K; Tago T; Toyohara J; Sengoku R; Nishina Y; Kanemaru K; Ishibashi K; Murayama S; Ishii K
J Alzheimers Dis; 2020; 73(1):197-207. PubMed ID: 31771066
[TBL] [Abstract][Full Text] [Related]
14. PET studies in dementia.
Herholz K
Ann Nucl Med; 2003 Apr; 17(2):79-89. PubMed ID: 12790355
[TBL] [Abstract][Full Text] [Related]
15. Brain
Woyk K; Sahlmann CO; Hansen N; Timäus C; Müller SJ; Khadhraoui E; Wiltfang J; Lange C; Bouter C
J Neuroimaging; 2023 Mar; 33(2):256-268. PubMed ID: 36465027
[TBL] [Abstract][Full Text] [Related]
16. Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.
Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
Exp Neurol; 2005 Feb; 191 Suppl 1():S95-S103. PubMed ID: 15629765
[TBL] [Abstract][Full Text] [Related]
17. Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
Lee YH; Jeon S; Yoo HS; Chung SJ; Jung JH; Baik K; Sohn YH; Lee PH; Yun M; Evans AC; Ye BS
J Alzheimers Dis; 2021; 79(4):1471-1487. PubMed ID: 33459638
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
19. [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease.
Okamura N; Arai H; Higuchi M; Tashiro M; Matsui T; Hu XS; Takeda A; Itoh M; Sasaki H
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):447-56. PubMed ID: 11294488
[TBL] [Abstract][Full Text] [Related]
20. Brain fluorodeoxyglucose (FDG) PET in dementia.
Kato T; Inui Y; Nakamura A; Ito K
Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
